Sp/NN
family/NN
members/NNS
preferentially/RB
interact/VBP
with/IN
the/DT
promoter/NN
proximal/JJ
repeat/NN
within/IN
the/DT
HTLV-I/NN
enhancer/NN
./.

Human/JJ
T/NN
cell/NN
lymphotropic/JJ
virus/NN
type/NN
I/CD
(/(
HTLV-I/NN
)/)
encodes/VBZ
the/DT
transactivator/NN
protein/NN
,/,
Tax/NN
,/,
which/WDT
facilitates/VBZ
viral/JJ
transcription/NN
from/IN
three/CD
21/CD
bp/NN
repeated/JJ
elements/NNS
within/IN
the/DT
U3/NN
region/NN
of/IN
the/DT
long/JJ
terminal/JJ
repeat/NN
(/(
LTR/NN
)/)
./.
=====
Examination/NN
of/IN
the/DT
basal/JJ
factors/NNS
interacting/VBG
with/IN
the/DT
21/CD
bp/NN
repeat/NN
elements/NNS
through/IN
electrophoretic/JJ
mobility/NN
shift/NN
(/(
EMS/NN
)/)
analyses/NNS
has/VBZ
demonstrated/VBN
the/DT
formation/NN
of/IN
DNA-protein/JJ
complexes/NNS
common/JJ
to/TO
each/DT
of/IN
the/DT
21/CD
bp/NN
repeats/NNS
(/(
C1-C3/NN
)/)
as/RB
well/RB
as/IN
three/CD
DNA-protein/JJ
complexes/NNS
specific/JJ
to/TO
the/DT
promoter/NN
proximal/JJ
(/(
pp/NN
)/)
repeat/NN
(/(
U1/NN
(/(
U1A/U1B/NN
)/)
and/CC
U2/NN
;/:
1-4/CD
)/)
./.
=====
These/DT
studies/NNS
have/VBP
indicated/VBN
that/IN
the/DT
individual/JJ
repeats/NNS
are/VBP
not/RB
identical/JJ
with/IN
respect/NN
to/TO
the/DT
cellular/JJ
factors/NNS
with/IN
which/WDT
they/PRP
interact/VBP
./.
=====
EMS/NN
analyses/NNS
utilizing/VBG
a/DT
series/NN
of/IN
mutated/VBN
pp/NN
repeat/NN
elements/NNS
demonstrate/VBP
that/IN
the/DT
nucleotide/NN
sequence/NN
requirements/NNS
for/IN
U1/NN
(/(
U1A/U1B/NN
)/)
and/CC
U2/NN
formation/NN
are/VBP
separable/JJ
from/IN
those/DT
required/VBN
for/IN
C1-C3/NN
formation/NN
./.
=====
Competition/NN
EMS/NN
analyses/NNS
utilizing/VBG
Sp1/NN
and/CC
CREB/NN
binding/NN
site/NN
oligonucleotides/NNS
demonstrate/VBP
that/IN
Sp/NN
family/NN
members/NNS
are/VBP
critical/JJ
components/NNS
of/IN
U1/NN
(/(
U1A/U1B/NN
)/)
and/CC
U2/NN
and/CC
that/IN
ATF/CREB/NN
family/NN
members/NNS
are/VBP
critical/JJ
components/NNS
of/IN
C1-C3/NN
./.
=====
EMS/NN
supershift/NN
analyses/NNS
have/VBP
demonstrated/VBN
that/IN
Sp1/NN
is/VBZ
involved/VBN
in/IN
U1A/NN
formation/NN
while/IN
Sp3/NN
is/VBZ
involved/VBN
in/IN
U1B/NN
and/CC
U2/NN
formation/NN
./.
=====
EMS/NN
analyses/NNS
performed/VBN
with/IN
nuclear/JJ
extracts/NNS
from/IN
Tax-expressing/JJ
Jurkat/NN
cells/NNS
and/CC
HTLV-I-transformed/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
demonstrate/VBP
that/IN
Tax/NN
prevents/VBZ
the/DT
formation/NN
of/IN
U1/NN
(/(
U1A/U1B/NN
)/)
and/CC
U2/NN
DNA-protein/JJ
complexes/NNS
./.
=====
Therefore/RB
,/,
Tax/NN
appears/VBZ
to/TO
inhibit/VB
the/DT
interaction/NN
of/IN
Sp/NN
family/NN
members/NNS
with/IN
the/DT
pp/NN
repeat/NN
./.
=====
Based/VBN
on/IN
these/DT
observations/NNS
,/,
it/PRP
is/VBZ
possible/JJ
that/IN
the/DT
interaction/NN
of/IN
Sp/NN
and/CC
ATF/CREB/NN
family/NN
members/NNS
with/IN
the/DT
pp/NN
repeat/NN
during/IN
basal/JJ
and/CC
Tax-mediated/JJ
transcription/NN
may/MD
play/VB
a/DT
critical/JJ
role/NN
in/IN
viral/JJ
gene/NN
expression/NN
during/IN
the/DT
initial/JJ
stages/NNS
of/IN
virus/NN
infection/NN
or/CC
during/IN
activation/NN
of/IN
a/DT
latent/JJ
infection/NN
./.